Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

2 Leading Ebola Vaccines Appear Safe, Further Tests Starting

January 9, 2015 8:51 am | by Maria Cheng - AP Medical Writer | News | Comments

The World Health Organization said the two leading Ebola vaccines appear safe and will soon be tested in healthy volunteers in West Africa. Read more...                  

TOPICS:

The Battle Brewing Over Hepatitis C Drugs

January 8, 2015 3:05 pm | by Ryan Bushey, Associate Editor | Articles | Comments

Abbvie and Gilead are fighting for control over this lucrative drug market. Read more...                            

TOPICS:

23andMe, Genentech Team Up for Research Project on Parkinson's Disease

January 8, 2015 2:03 pm | News | Comments

23andMe and Genentech will together to generate whole genome sequencing data for approximately 3,000 people in 23andMe's Parkinson's disease community. Read more...              

TOPICS:
Advertisement

Pfizer's New Cancer Drug May Get Early Approval

January 8, 2015 1:27 pm | by Linda A. Johnson - AP Business Writer | News | Comments

Analysts believe Pfizer's new cancer drug appears poised for approval within a few months and could be a new blockbuster. Read more...                    

TOPICS:

'Cellular Backpacks' Attach to White Blood Cells Targeting Inflammation

January 8, 2015 12:52 pm | by University of California, Santa Barbara | News | Comments

Persistent inflammation is often indicative of more serious conditions and can lead to problems of its own, including impaired healing, loss of function or even tissue death. Read more...            

TOPICS:

Broad Immune Response May Destroy Latent HIV

January 8, 2015 12:39 pm | by Yale University | News | Comments

A major barrier to finding a cure for HIV/AIDS is the presence of latent HIV in the cells of chronically infected individuals. Read more...                    

TOPICS:

Major Breakthrough in Reducing Cost of Key AIDS Drug

January 8, 2015 12:20 pm | by VCU | News | Comments

A team of researchers has invented a far more cost-effective way to manufacture a widely used AIDS drug. Read more...                        

TOPICS:

Pharming and Salix: HAE Trial's First Patient Treated

January 8, 2015 10:26 am | by Ruconest | News | Comments

Pharming Group NV and Salix Pharmaceuticals, Ltd. announced that the first patient was treated in their Phase 2 clinical study of Ruconest, (C1 Esterase Inhibitor [Recombinant]) 50 IU/kg, for prophylaxis in patients with hereditary angioedema (HAE).  Read more...

TOPICS:
Advertisement

Vatican Earmarks $3.55 Million for Ebola Care

January 8, 2015 10:21 am | by Associated Press | News | Comments

The Vatican is increasing assistance to Western African countries hard-hit by the Ebola virus, setting aside 3 million euros ($3.55 million) to fund protective gear for care-givers, transport for sick patients and care for orphans left behind. 

TOPICS:

Snail Venom Sting in Tail of Cancer, Addiction

January 8, 2015 10:16 am | by University of Queensland | News | Comments

Cone snail venom has given University of Queensland researchers a lead on the possible detection and treatment of some cancers and addictions. Read more...                                  

TOPICS:

First Patient Successfully Transplanted with Cytopreserved Cord Blood

January 8, 2015 10:10 am | by Gamida Cell | News | Comments

Gamida Cell, a leader in cell therapy technologies and products for transplantation and adaptive immune therapy, announced today that the first person has been successfully transplanted with cryopreserved (frozen) NiCord in the company's ongoing Phase 1/2 clinical study for blood cancer patients. 

TOPICS:

Eisai Responds: Decision to Remove Halaven Therapy from CDF

January 8, 2015 10:03 am | by Eisai | News | Comments

Eisai announced its extreme disappointment that the National Cancer Drugs Fund (NCDF) panel has apparently made the decision to remove Halaven(eribulin) from the Cancer Drugs Fund (CDF), following a process of arbitrary evaluation. Read more...

TOPICS:

New Clues: Why Older Women Are More Susceptible to Breast Cancer

January 8, 2015 9:05 am | by Skip Derra, Contributing Writer | Articles | Comments

The idea that breast cancer becomes more prevalent with age is fairly well established, but the reasons why are still uncertain. Now, scientists from the Lawrence Berkeley National Laboratory have new insights into why older women are more susceptible to breast cancer. Read more...

TOPICS:

Vitamin B May Counter Negative Effects of Pesticide on Fertility

January 8, 2015 8:33 am | by Johns Hopkins University | News | Comments

Women who have adequate levels of B vitamins in their bodies are more likely to get and stay pregnant even when they also have high levels of a common pesticide known to have detrimental reproductive effects. Read more...       

TOPICS:

FDA Endorses First Low Cost Biotech Drug

January 8, 2015 8:26 am | by Matthew Perrone - AP Health Writer | News | Comments

Federal health experts have unanimously endorsed a Novartis drug which is expected to become the first lower-cost copy of a biotech drug to reach the U.S. market. Read more...              

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading